Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
about
Citalopram versus other anti-depressive agents for depressionEscitalopram versus other antidepressive agents for depressionEscitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trialTreating Chronic Pain with SSRIs: What Do We Know?Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials.The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.Why do some promising brain-stimulation devices fail the next steps of clinical development?Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopramEscitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysisA metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.Comparative efficacy of escitalopram in the treatment of major depressive disorder.Escitalopram therapy for major depression and anxiety disorders.Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study.Managing depressive and anxiety disorders with escitalopram.Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.In vivo investigation of escitalopram's allosteric site on the serotonin transporterEfficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial.The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.Escitalopram in the treatment of obsessive-compulsive disorder.Escitalopram for the treatment of major depression and anxiety disorders.Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.Treating each and every depressed patient.Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.Escitalopram causes fewer seizures in human overdose than citalopram.Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram.Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study.What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology.Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders.Silver-catalyzed C-C bond formation with carbon dioxide: significant synthesis of dihydroisobenzofurans.A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.Efficacy and safety of escitalopram in treatment of severe depression in Chinese population.The Evergreening of Biopharmaceuticals: Time to Defoliate.
P2860
Q24202141-31D63721-0BC5-40C7-8B13-CC1D375DBA28Q24241065-D5BCEDCC-488F-4459-8783-68136E2C413AQ24655535-D9971EBE-F5F3-49DE-BADF-5A96A7FA5CAAQ26738470-17734BAE-716D-4D60-86DC-5CFF39E33D22Q30493395-E59B164F-9931-4DD4-A8F3-7F0DCAFB8912Q33453953-1B754AF1-D961-43CD-8764-D8148372085AQ33519672-82ED453C-701D-4BC6-9662-5D903A62FE51Q33618813-12677675-B75E-47FB-81C0-1AAEFA7137E1Q33932339-564358A8-0E28-4F4A-B48A-A1749A90E08EQ34072466-AA1DBDC1-3222-4C2C-83FB-5CA60F117B6BQ34480541-AD8D4789-B07C-456D-B066-FF46254FF59AQ34590910-807D753A-C4DC-4B99-A087-296859DED710Q34622235-4E54C856-FF9A-4E39-A99F-FC4444DD6629Q34664591-F1C44364-C6F8-495D-B95F-5D83F18D5F85Q34685982-B6878370-6815-445A-AD6D-56AF4F6D8748Q35066804-2D403B5A-6E77-418B-B7C3-174A2AFFE8E6Q35106010-77CFA371-EF7B-4521-885A-2688CB3B23C6Q35137131-CB119ED9-DC5A-46F4-A50F-AA827258E0BAQ36160446-B104F9C7-F858-4215-A4AE-BDDCECA38702Q36407369-931BED8B-5616-4809-AB97-EF5B5606DEABQ36479510-CBDD7FBE-9B06-41CE-BA11-9FC4946CBF3DQ36494042-696EB4EB-1EAA-4BB3-9696-A4B91019CC5FQ36606752-9C0A48D5-790A-40C5-B8DD-27B1BB58309BQ36960563-435AB5FD-DF47-496B-88BF-B4131360C12DQ37111879-1CB16349-915A-43C2-A8E1-0429D85CE8A8Q37139768-65F7E3EE-60FD-4574-A276-F02243F35215Q37202188-530BA2BF-526A-4492-B268-61C1DB612C60Q37254743-4F119116-AE18-4286-8986-F9B3593D5B9CQ37503551-50A33EAD-6A07-412B-A2E7-F527143B2134Q37695292-92623991-F6BD-4965-BB0D-3963EC13A12CQ37948756-7CBDF126-284A-4764-A3A8-3D568B5DEAE4Q39326067-B2392A46-89FE-4403-B793-1BF5A8DC0B13Q42129272-2FB13721-F46A-4BD2-A733-1AB828601889Q42618085-7B491BE5-6511-4153-ACB7-972C87D116CEQ42955459-375EA618-B3D9-448B-82D2-FB50AB016018Q43042829-A64574C2-2AFC-4ED6-91B5-39F663D473F0Q45110335-E55BE9FB-C3BE-417F-9CDE-4DA12A2AA990Q46726992-8D404FE4-28F7-4392-8C3C-48CA0C29777FQ47774710-A6ECEFFF-48A9-46BF-8D6C-63A1EBF545B6Q48074416-A9D888D0-8392-4E02-9AC2-37CA1ABEF7CA
P2860
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prospective, multicentre, rand ...... of major depressive disorder.
@ast
Prospective, multicentre, rand ...... of major depressive disorder.
@en
Prospective, multicentre, rand ...... of major depressive disorder.
@nl
type
label
Prospective, multicentre, rand ...... of major depressive disorder.
@ast
Prospective, multicentre, rand ...... of major depressive disorder.
@en
Prospective, multicentre, rand ...... of major depressive disorder.
@nl
prefLabel
Prospective, multicentre, rand ...... of major depressive disorder.
@ast
Prospective, multicentre, rand ...... of major depressive disorder.
@en
Prospective, multicentre, rand ...... of major depressive disorder.
@nl
P2093
P1476
Prospective, multicentre, rand ...... of major depressive disorder.
@en
P2093
Bruno Fantino
Hélène Verdoux
Nicholas Moore
P304
P356
10.1097/00004850-200505000-00002
P577
2005-05-01T00:00:00Z